January 21, 2020 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announced it has successfully completed its...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
-
-
A venous-venous (VV) extracorporeal membrane oxygenation (ECMO) implantation procedure in a cath lab at...
-
This video shows the first robotic percutaneous coronary interventions (PCI) performed in Germany with the Robocath R-One robotic catheter guidance system.
-
January 15, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert consensus statement for the...
Videos | Robotic Systems | January 20, 2020
This video shows the first robotic percutaneous coronary interventions (PCI) performed in Germany with the Robocath...
Professor Michael Haude, director of Medical Clinic I at Rheinland Klinikum Neuss Lukaskrankenhaus, performing a PCI using the Robocath R-One robotic catheter guidance system.
News | January 21, 2020
January 21, 2020 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for...
News | Radial Access | January 15, 2020
January 15, 2020 — The Society for Cardiovascular Angiography and...
Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit.
News | Cardiac Rehabilitation | January 15, 2020
January 15, 2020 – Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a...
This is the latest version of the MitraClip, the G4, which allows each side of the clip to be opened and closed independently to offer more flexibility when capturing the valve leaflets. The device is being used in the REPAIR MR clinical trial.
News | Heart Valve Technology | January 13, 2020
January 13, 2020 — The U.S. Food and Drug Administration (FDA) has approved clinical trial that will compare the...
Videos | Hemodynamic Support Devices | January 09, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, and Melissa...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.
News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European...
Ten out of the top 25 videos in 2019 are from hospital site visits DAIC conducted and shot more than 10 video interviews and recorded cath lab procedures at each center. Two of the videos here are walk throughs of cath labs, showing how Henry Ford Hospital and the University of Colorado set up their main hybrid rooms for structural heart procedures. This photo is from a MitraClip procedure during the University of Colorado visit last December.
Feature | December 30, 2019 | Dave Fornell, Editor
Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These...
News | Radial Access | December 30, 2019
December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of...
News | Cardiovascular Business | December 30, 2019
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures. For...
The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).
Feature | Antiplatelet and Anticoagulation Therapies | December 27, 2019
December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics...
The high cost of EP mapping and ablation catheters consumes about 60 percent of CMS reimbursement for atrial fibrillation catheter ablation procedures. This has led some hospitals to start reprocessing the catheters to cut costs. Photo by Dave Fornell.
Blog | Cardiovascular Business | December 23, 2019
With all eyes on rising healthcare costs, reprocessing of single-use devices has become an increasingly important...
